학술논문
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial
Document Type
Article
Author
Loverix, Liselore; Vergote, Ignace; Busschaert, Pieter; Vanderstichele, Adriaan; Venken, Tom; Boeckx, Bram; Harter, Philipp; Brems, Hilde; Van Nieuwenhuysen, Els; Pignata, Sandro; Baert, Thaïs; Gonzalez-Martin, Antonio; Han, Sileny; Marth, Christian; Neven, Patrick; Colombo, Nicoletta; Berteloot, Patrick; Mäenpää, Johanna; Olbrecht, Siel; Laga, Tina; Sablon, Erwin; Ray-Coquard, Isabelle; Pujade-Lauraine, Eric; Lambrechts, Diether; Van Gorp, Toon
Source
In European Journal of Cancer July 2023 188:131-139
Subject
Language
ISSN
0959-8049